An Unusual Presentation of Vogt–Koyanagi–Harada

This is a Photo Essay and does not have an abstract. Please download the PDF or view the article in HTML

Digital Gangrene in Antiphospholipid Syndrome: Digital Gangrene

ARTICLE WITHDRAWN FOR LEGAL REASONS For legal reasons, the publisher has withdrawn permission for online, public display of this article

Effectiveness of Tocilizumab in a COVID-19 Patient with Cytokine Release Syndrome

Cytokine release syndrome (CRS) is a systemic inflammatory response that can be triggered by many factors such as infections. CRS in patients with coronavirus disease 2019 (COVID-19) is life-threatening and can occur very rapidly after COVID-19 diagnosis. Tocilizumab (TCZ), an interleukin-6 (IL-6) inhibitor, may ameliorate the CRS associated with severe COVID-19 and thus improve clinical outcomes. We present a case of life-threatening CRS caused by COVID-19 infection successfully treated with TCZ